<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/133729.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Sequoia Pharmaceuticals Secures Funding to Test its Unique AIDS Drug</title>
     <link>http://www.prweb.com/releases/2005/03/prweb219954.htm</link><description>   <![CDATA[ <P>Sequoia Pharmaceuticals, Inc., a company focused on discovering novel drugs to combat drug-resistant viral infections, today announced that it closed on a $22 million Series B round of financing. The financing is expected to fund early stage clinical trials of the Company&#8217;s novel drug designed to combat wild-type- and multi-drug-resistant strains of HIV. (PRWeb Mar 20, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/03/prweb219954.htm">http://www.prweb.com/releases/2005/03/prweb219954.htm</a></P>]]>
                </description><pubDate>Sun, 20 Mar 2005 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/03/prweb219954.htm</guid>
        </item>
</channel>
</rss>